Famotidine
- Product NDC
- 21130-191
- 11-digit product format
- 211300191
- Labeler code
- 21130
- Product ID
- 21130-191_463f1b83-03cb-ec46-e063-6294a90a7168
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Famotidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- SAFEWAY
- Application
- ANDA215822
- Marketing category
- ANDA
- Marketing start
- 2023-06-30
- Substance
- FAMOTIDINE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Famotidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FAMOTIDINE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5QZO15J2Z8 |
| Rxcui | 310273 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 21130-191-20 | Famotidine | 200 in 1 BOTTLE | TABLET | 200 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 21130-191 | FAMOTIDINE TABLET [SAFEWAY] | 4 | Current NDC, 1 package rows | 20241228_f18c1195-48a1-69dc-e053-2a95a90a4077.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 21130-191-20 | 21130019120 | 200 TABLET in 1 BOTTLE (21130-191-20) | 200 tablet | 2023-06-30 | No | No | Current |